SEC Form 4 · accession 0001144204-16-078549
TITAN PHARMACEUTICALS INC · TTNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marc Rubin
Officer — Executive Chairman · Director
Period of report
Feb 2, 2016
Accepted (ET)
Feb 2, 2016 · 5:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000910267
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $5.10 | Feb 2, 2016 | A | 79,100 | A | — | Feb 2, 2026 | Common Stock | 79,100 | 79,100 | D |
Explanation of responses
- F1The options vest in 24 equal monthly installments commencing on the grant date.